JP2011137045A5 - - Google Patents

Download PDF

Info

Publication number
JP2011137045A5
JP2011137045A5 JP2011086840A JP2011086840A JP2011137045A5 JP 2011137045 A5 JP2011137045 A5 JP 2011137045A5 JP 2011086840 A JP2011086840 A JP 2011086840A JP 2011086840 A JP2011086840 A JP 2011086840A JP 2011137045 A5 JP2011137045 A5 JP 2011137045A5
Authority
JP
Japan
Prior art keywords
group
olefin
aromatic
acid
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011086840A
Other languages
English (en)
Japanese (ja)
Other versions
JP5629632B2 (ja
JP2011137045A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011137045A publication Critical patent/JP2011137045A/ja
Publication of JP2011137045A5 publication Critical patent/JP2011137045A5/ja
Application granted granted Critical
Publication of JP5629632B2 publication Critical patent/JP5629632B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011086840A 2003-09-25 2011-04-08 9,10−α,α−OH−タキサンアナログおよびその生成のための方法 Expired - Lifetime JP5629632B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50668003P 2003-09-25 2003-09-25
US60/506,680 2003-09-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006528316A Division JP4874102B2 (ja) 2003-09-25 2004-09-27 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014141964A Division JP6106634B2 (ja) 2003-09-25 2014-07-10 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Publications (3)

Publication Number Publication Date
JP2011137045A JP2011137045A (ja) 2011-07-14
JP2011137045A5 true JP2011137045A5 (https=) 2012-05-24
JP5629632B2 JP5629632B2 (ja) 2014-11-26

Family

ID=34393186

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2006528316A Expired - Lifetime JP4874102B2 (ja) 2003-09-25 2004-09-27 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2010200399A Expired - Lifetime JP5525394B2 (ja) 2003-09-25 2010-09-07 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2011086840A Expired - Lifetime JP5629632B2 (ja) 2003-09-25 2011-04-08 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2014141964A Expired - Lifetime JP6106634B2 (ja) 2003-09-25 2014-07-10 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2016137271A Expired - Lifetime JP6216417B2 (ja) 2003-09-25 2016-07-12 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2006528316A Expired - Lifetime JP4874102B2 (ja) 2003-09-25 2004-09-27 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2010200399A Expired - Lifetime JP5525394B2 (ja) 2003-09-25 2010-09-07 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014141964A Expired - Lifetime JP6106634B2 (ja) 2003-09-25 2014-07-10 9,10−α,α−OH−タキサンアナログおよびその生成のための方法
JP2016137271A Expired - Lifetime JP6216417B2 (ja) 2003-09-25 2016-07-12 9,10−α,α−OH−タキサンアナログおよびその生成のための方法

Country Status (14)

Country Link
US (8) US7745650B2 (https=)
EP (2) EP1664033B1 (https=)
JP (5) JP4874102B2 (https=)
CN (1) CN1886400A (https=)
AT (1) ATE377593T1 (https=)
AU (1) AU2004275881A1 (https=)
CA (1) CA2539975C (https=)
DE (1) DE602004009943T2 (https=)
DK (1) DK1664033T3 (https=)
ES (1) ES2295937T3 (https=)
HR (1) HRP20080057T3 (https=)
PL (1) PL1664033T3 (https=)
PT (1) PT1664033E (https=)
WO (1) WO2005030150A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2539975C (en) 2003-09-25 2012-11-20 Tapestry Pharmaceuticals, Inc. 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
WO2007075870A2 (en) * 2005-12-21 2007-07-05 Tapestry Pharmaceuticals, Inc. Processes for taxane derivatives and intermediates useful therein
CN101370798A (zh) * 2005-12-21 2009-02-18 挂毯药品公司 用于形成紫杉烷的新化合物和方法及其应用
JP2009531446A (ja) * 2006-03-27 2009-09-03 タペストリー ファーマシューティカルズ インコーポレーテッド タキサン誘導体の合成のためのコンバージェントプロセス
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
US7847111B2 (en) 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
EP2029563A4 (en) * 2006-06-12 2009-12-02 Canada Inc 6570763 HALF-SYNTHETIC ROUTE FOR THE PREPARATION OF PACLITAXEL, DOCETAXEL AND 10-DEACETYLBACCATIN III FROM 9-DIHYDRO-13-ACETYLBACCATIN III
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
WO2008109360A1 (en) * 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
US9227983B2 (en) 2011-04-07 2016-01-05 Arbor Therapeutics, LLC Taxane and abeo-taxane analogs
MX2013011694A (es) * 2011-04-07 2014-05-27 Arbor Therapeutics Llc Analogos de taxano y abeo-taxanos.
CN103763928B (zh) * 2011-06-06 2016-09-21 阿伯疗法责任有限公司 癌症化疗剂的酸不稳定的亲脂性前体药物
PL4096588T3 (pl) 2020-03-04 2025-01-07 Aquedeon Medical, Inc. Narzędzie do zakładania łączników do przeszczepów naczyniowych i aortalnych z osłoną teleskopową

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US6794523B2 (en) * 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
JPH07505887A (ja) * 1992-04-17 1995-06-29 アボツト・ラボラトリーズ タキソール誘導体
FR2697019B1 (fr) * 1992-10-15 1994-11-25 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
CA2147984C (en) 1992-11-13 2006-03-14 Robert A. Holton Butenyl-substituted taxanes and composition
WO1994020088A1 (en) 1993-03-05 1994-09-15 Florida State University C9 taxane derivatives and pharmaceutical compositions containing them
WO1994020485A1 (en) * 1993-03-05 1994-09-15 Florida State University Process for the preparation of 9-desoxotaxanes
US6710191B2 (en) * 1993-03-05 2004-03-23 Florida State University 9β-hydroxytetracyclic taxanes
ATE284689T1 (de) 1993-03-22 2005-01-15 Univ Florida State Pharmazeutische zusammenstellungen enthaltende eine furyl oder thienyl substituierte seitenkette
FR2707293A1 (fr) * 1993-07-08 1995-01-13 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2715846A1 (fr) * 1994-02-07 1995-08-11 Rhone Poulenc Rorer Sa Nouvelle composition pharmceutique à base de taxoïdes.
IT1275936B1 (it) 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5739359A (en) * 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
US6048990A (en) * 1998-05-01 2000-04-11 Napro Biotherapeutics, Inc. Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
CZ20013523A3 (cs) 2000-02-02 2002-03-13 Florida State University Research Foundation, Inc. Taxany s C10 heterosubstituovaným acetátem jako protinádorové látky
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
CA2441484A1 (en) 2001-03-23 2002-10-03 Napro Biotherapeutics, Inc. Molecular conjugates for use in treatment of cancer
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
CA2470826A1 (en) 2001-12-20 2003-07-03 Bristol-Myers Squibb Company Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
US6898834B1 (en) * 2003-03-03 2005-05-31 Westbridge Pty Ltd Barrel stave reclaim
CA2539975C (en) * 2003-09-25 2012-11-20 Tapestry Pharmaceuticals, Inc. 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof
EP1894921A3 (en) 2003-09-25 2008-03-12 Tapestry Pharmaceuticals, Inc. 9, 10-Alpha, Alpha-Oh-Taxane analogs and methods for production thereof
AU2006247471A1 (en) 2005-05-12 2006-11-23 Tapestry Pharmaceuticals, Inc. Molecular constructs suitable for targeted conjugates
CN101370798A (zh) 2005-12-21 2009-02-18 挂毯药品公司 用于形成紫杉烷的新化合物和方法及其应用
WO2007075870A2 (en) 2005-12-21 2007-07-05 Tapestry Pharmaceuticals, Inc. Processes for taxane derivatives and intermediates useful therein
JP2009531446A (ja) 2006-03-27 2009-09-03 タペストリー ファーマシューティカルズ インコーポレーテッド タキサン誘導体の合成のためのコンバージェントプロセス
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US20080207743A1 (en) 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
WO2008109360A1 (en) 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer

Similar Documents

Publication Publication Date Title
JP2011137045A5 (https=)
JP2012092103A5 (https=)
JP2017222697A5 (https=)
JP2013532130A5 (https=)
JP2014500861A5 (https=)
JP2014526533A5 (https=)
JP2012144574A5 (https=)
JP2010095546A5 (https=)
JP2011105738A5 (https=)
JP2007506792A5 (https=)
JP2011518833A5 (https=)
JP2015096949A5 (https=)
JP2013508347A5 (https=)
JP2013546173A5 (https=)
JP2016503797A5 (https=)
JP2015042636A5 (ja) 有機化合物
JP2013505929A5 (https=)
JP2016505614A5 (https=)
JP2016520672A5 (https=)
JP2013543842A5 (https=)
JP2016525130A5 (https=)
JP2012012417A5 (https=)
JP2011227454A5 (https=)
JP2015199738A5 (https=)
JP2012094862A5 (https=)